Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis - Designing a Prospective Observational Study in South Africa.

Kastien-Hilka T, Rosenkranz B, Bennett B, Sinanovic E, Schwenkglenks M.

Front Pharmacol. 2016 May 31;7:125. doi: 10.3389/fphar.2016.00125. eCollection 2016.

2.

Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa.

Kastien-Hilka T, Abulfathi A, Rosenkranz B, Bennett B, Schwenkglenks M, Sinanovic E.

Health Qual Life Outcomes. 2016 Mar 11;14:42. doi: 10.1186/s12955-016-0442-6. Review.

3.

Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale.

Cunnama L, Sinanovic E, Ramma L, Foster N, Berrie L, Stevens W, Molapo S, Marokane P, McCarthy K, Churchyard G, Vassall A.

Health Econ. 2016 Feb;25 Suppl 1:53-66. doi: 10.1002/hec.3295. Epub 2016 Jan 14.

PMID:
26763594
4.

Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.

Ramma L, Cox H, Wilkinson L, Foster N, Cunnama L, Vassall A, Sinanovic E.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1513-9. doi: 10.5588/ijtld.15.0341.

PMID:
26614194
5.

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, Sinanovic E, Cox HS, Dye C, Grant AD, Fielding KL.

Lancet Glob Health. 2015 Aug;3(8):e450-7. doi: 10.1016/S2214-109X(15)00100-X.

6.

The costs of accessing abortion in South Africa: women's costs associated with second-trimester abortion services in Western Cape Province.

Lince-Deroche N, Constant D, Harries J, Blanchard K, Sinanovic E, Grossman D.

Contraception. 2015 Oct;92(4):339-44. doi: 10.1016/j.contraception.2015.06.029. Epub 2015 Jul 2.

PMID:
26142621
7.

Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.

Cox H, Ramma L, Wilkinson L, Azevedo V, Sinanovic E.

Trop Med Int Health. 2015 Oct;20(10):1337-45. doi: 10.1111/tmi.12544. Epub 2015 Jun 1.

8.

The economic burden of TB diagnosis and treatment in South Africa.

Foster N, Vassall A, Cleary S, Cunnama L, Churchyard G, Sinanovic E.

Soc Sci Med. 2015 Apr;130:42-50. doi: 10.1016/j.socscimed.2015.01.046. Epub 2015 Jan 27.

9.

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, McCarthy K, Churchyard G, Cox H.

Int J Tuberc Lung Dis. 2015 Feb;19(2):172-8. doi: 10.5588/ijtld.14.0421.

10.

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa.

Channing L, Sinanovic E.

Cost Eff Resour Alloc. 2014 Sep 16;12:20. doi: 10.1186/1478-7547-12-20. eCollection 2014.

11.

Shorter drug regimens for tuberculosis: the multiple applications of decision models.

Holland DP, Sinanovic E.

Int J Tuberc Lung Dis. 2013 May;17(5):569. doi: 10.5588/ijtld.13.0204. No abstract available.

PMID:
23575318
12.

Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.

Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS, Marais BJ, Sinanovic E.

Thorax. 2013 Mar;68(3):247-55. doi: 10.1136/thoraxjnl-2011-200933. Epub 2012 Jun 20.

PMID:
22717944
13.

Key issues in the clinical development and implementation of TB vaccines in South Africa.

Rustomjee R, Mcleod R, Hanekom W, Steel G, Mahomed H, Hawkridge A, Welte A, Sinanovic E, Loots G, Grobler A, Mvusi L, Gray G, Hesseling A, Ginsberg A, Lienhardt C, Shea J, Tong X, Lockhart S, Churchyard GJ.

Tuberculosis (Edinb). 2012 Sep;92(5):359-64. doi: 10.1016/j.tube.2012.05.001. Epub 2012 Jun 12.

PMID:
22698868
14.

The role of health economics research in implementation research for health systems strengthening.

Mann GH, Thomson R, Jin C, Phiri M, Vater MC, Sinanovic E, Squire SB.

Int J Tuberc Lung Dis. 2011 Jun;15(6):715-21. doi: 10.5588/ijtld.10.0749.

PMID:
21575290
15.

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R.

BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54.

16.

The utilization of health care services by children with Foetal Alcohol Syndrome in the Western Cape, South Africa.

Credé S, Sinanovic E, Adnams C, London L.

Drug Alcohol Depend. 2011 Jun 1;115(3):175-82. doi: 10.1016/j.drugalcdep.2010.10.019. Epub 2010 Dec 4.

PMID:
21131141
17.

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.

Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J.

Vaccine. 2009 Oct 19;27(44):6196-202. doi: 10.1016/j.vaccine.2009.08.004. Epub 2009 Aug 19. Erratum in: Vaccine. 2010 Aug 9;28(35):5755.

PMID:
19698807
18.

The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa.

Sinanovic E, Kumaranayake L.

Glob Public Health. 2010;5(5):479-92. doi: 10.1080/17441690902942498.

PMID:
19479590
19.

Preparing for HPV vaccination in South Africa: key challenges and opinions.

Harries J, Moodley J, Barone MA, Mall S, Sinanovic E.

Vaccine. 2009 Jan 1;27(1):38-44. doi: 10.1016/j.vaccine.2008.10.033. Epub 2008 Oct 31.

PMID:
18977271
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk